• October 1939

    Dai Nippon Zoki Research Institute founded in Ikuno-ku, Osaka-shi
    (Representative: Katsuma Sotojiro)

  • April 1942

    Head Office and Factory relocated to Hirano-ku, Osaka-shi

  • June 1949

    Nippon Zoki Allergy Research Institute established for the study and treatment of allergic diseases

  • December 1954

    Konishi Jin-emon joins management as an Executive Advisor

  • April 1960

    Jiro Sugano assumes presidency

  • August 1960

    General sales agent agreement with Shionogi & Co., Ltd. amicably dissolved to start independent marketing

  • January 1961

    Renamed as Nippon Zoki Pharmaceutical Co., Ltd.

  • May 1964

    Executive Advisor Konishi Jin-emon assumes presidency

  • May 1965

    Business alliance agreements signed with Biobasal (Switzerland) and Promedica (France)

  • October 1970

    The first French-Japanese Meeting on Allergology held at the University of Paris (subsequently held alternately in Japan and France every three years)

  • April 1971

    Aeropur Japan Co., Ltd. established to manufacture and market the Aeropur® anti-air pollution control system

  • November 1976

    Neurotropin® Special 3 cc released

  • October 1980

    The first Chinese-Japanese Meeting on Immunology and Allergology held in Beijing and Shanghai, China

  • March 1982

    China-Japan Immunology and Hematology Research Center jointly established in Shanghai with the Chinese Ministry of Public Health, with the aim of promoting exchanges in basic medicine and human resources development

  • June 1983

    Completion of the Institute of Bio-Active Science (IBAS)

  • November 1983

    Konishi Foundation for International Exchange founded under charter by the Japanese Minister of Foreign Affairs

  • April 1985

    The first U.S.S.R.-Bulgaria-Japan Meeting on Physiology of Emotion held in the IBAS International Conference Hall

  • October 1985

    The first French-Japanese-Chinese Meeting on Immunology and Allergology (the sixth French-Japanese Meeting on Allergology and the fifth Chinese-Japanese Meeting on Immunology and Allergology) held in Beijing and Shanghai, China

  • November 1985

    IBAS receives the Green Architecture Prize as part of the Hyogo Prefecture Parks and Greenery Concept

  • April 1986

    Completion of Ono Ryokuen FactoryNZP group founded for the company's self-protection

  • July 1987

    The first Chinese-Japanese Shanghai International Medical Seminar held

  • July 1988

    Neurotropin® tablet released

  • October 1988

    The seventh French-Japanese Meeting on Allergology (20th anniversary event) held in Clos de Vougeot, France

  • January 1994

    Beijing Liaison Office opened

  • September 1994

    Shanghai Konishi Biological Technology Co., Ltd. (Japan-China joint venture) foundedImport of Neurotropin® tablet approved in China

  • November 1994

    Import of Neurotropin® Special 3 cc approved in China

  • November 1996

    Completion of Technology Research Laboratories

  • May 1999

    Completion of Konishi-MUSC Institute for Inflammation Research

  • January 2002

    Konishi Ryusaku assumes presidency

  • May 2005

    Completion of Shanghai Konishi Biological Technology's Spark Factory

  • December 2005

    Completion of Ono Ryokuen Factory Manufacturing Building No. 2

  • April 2008

    Completion of Formulation Research Laboratories

  • August 2008

    Raw material facility completed in Vietnam

  • June 2011

    Xiaoxi Medical Consulting (Beijing) Co., Ltd. founded

  • December 2011

    Konishi Biotechnology Vietnam Co., Ltd. founded

  • December 2013

    Nippon Zoki Vietnam Co., Ltd. founded

  • January 2017

    Nippon Zoki Vietnam completes the first phase of raw material facility construction in Yên Bái, Vietnam

  • March 2020

    First-class marketing license for medical devices obtained

  • August 2020

    Head Office relocated to 4-chome, Hiranomachi, Chuo-ku, Osaka-shi

  • June 2023

    Konishi Takafumi assumes presidency